Vaccine Production Summit Case Study: Downstream Process Development For Vaccines Using CHT™ Ceramic Hydroxyapatite Media
Global vaccine manufacturers have significantly increased their commitment to innovation. Established and next generation vaccines using recombinant technologies and a variety of host cells, present new purification challenges. Learn more on June 4 in San Francisco, CA.
Getting A Biotech Back On The Path Toward Commercialization By Rob Wright, Life Science Leader magazine
There has been much debate as to how much it costs to get a new drug from discovery to market — anywhere from Light and Waburton’s 2011 estimate of R&D costs being in the neighborhood of $59.4M to PhRMA’s mind-numbing figure of $1.32B.
The Evolution Of Biotech VC Funding By Suzanne Elvidge
Rather than just providing funding to already-established companies, PureTech Ventures works with scientists to create companies from the ground up — from establishing a leadership team through to creating syndicates for later-stage financing rounds.
Brochure: High-Purity Diaphragm Valves Aquasyn does not just offer an industrial diaphragm valve that has been converted to meet industry requirements, but products which are conceived and executed specifically to meet the needs of the bio-pharmaceutical industry.
Skid-Mounted Liquid Chromatography Systems IPEC provided three skid-mounted liquid chromatography systems to Cook Pharmica, located in Bloomington, IN. The systems consisted of piping, valves, pumps, filters, bubble traps, and instrumentation, and are suitable for operation under cGMP guidelines.